Nontuberculous Mycobacterium Treatment Market Share

On the basis of geographical analysis, the global nontuberculous mycobacterium treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Asia Pacific industry is predicted to hold largest revenue share by 2036, on the back of improving healthcare infrastructure, along with growing geriatric population in the region.

The market in the North America region is anticipated to gain the largest market share throughout the forecast period on the back of high prevalence of nontuberculous mycobacterium infections. The high healthcare expenditure, presence of major pharmaceutical companies, and increasing research activities for the development of new drugs, are further estimated to boost the market growth. According to the statistics by the World Bank, in 2018, North America spent USD 10,050.516 for the healthcare of every individual. The total healthcare expenditure accounted for 16.415% of the total GDP of North America in the same year.